Skip to main content

Advertisement

Log in

Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

In Hexi area of Gansu Province, people have a higher susceptibility of gastric cancer than people in the rest area of China. There is substantial geographic variation in the incidence of gastric cancer. In this article, the present author explored the roles of H. pylori infection and IL-10 promoter polymorphisms in development of gastric cancer in this area. A total of 304 participants were admitted to our study, and they were divided into two groups: control group and case group. Blood samples from all subjects were collected for gene extraction using DNA extraction kits. IL-10 polymorphisms were determined by SNaPshot Multiplex. To test H. pylori infection and its typing H. pylori antibody Immunoblotting Kits were used. This research suggested that environmental factor played an important role in the pathogenesis of gastric carcinoma in the area, H. pylori infection increased the risk of gastric cancer (OR = 2.612, 95% CI 1.636–4.170) and subject with H. pylori I-type positive was at significantly higher risk for progression to gastric cancer (OR = 4.712, 95% CI 2.656–8.537). For subjects with the ATA/GCC or GCC/GCC haplotype of the IL-10−1082/−819/−592 polymorphism relative to the ATA/ATA haplotype group, the risk of gastric cancer development was significantly increased. It has been demonstrated that the presence of IL-10−819 C alleles and IL-10−592 C alleles was associated with an increased risk for gastric cancer development in H. pylori-infected patients and IL-10 promoter polymorphisms and H. pylori have a synergistic effect on gastric cancer in Hexi population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Masoud A, Fanny J, Anton EK (2011) The decline in stomach cancer mortality: exploration of future trends in seven European countries. Eur J Epidemiol 26:23–28

    Article  Google Scholar 

  3. Henk H, Edwin PMJ, Nicole CTG, Cornelis JHV (2009) Gastric cancer. Lancet 374(9701):1594–1595

    Google Scholar 

  4. Yamaoka Y, Kato M, Asaka M (2008) Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains. Intern Med 47:1077–1083

    Article  PubMed  Google Scholar 

  5. Peter H, Stephan G (2003) Gastric cancer. Lancet 362:305–315

    Article  Google Scholar 

  6. Hocker M, Peter H (2003) Helicobacter pylori virulence factors—one part of a big picture. Lancet 362(9391):1231–1233

    Article  PubMed  Google Scholar 

  7. Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, Lin MT, Wang HP, Lin JT (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein–Barr virus associated gastric carcinoma. J Infect Dis 185:106–109

    Article  PubMed  CAS  Google Scholar 

  8. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV (1997) An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 24:1–8

    Article  PubMed  CAS  Google Scholar 

  9. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, Gerhard M, Prinz C (2004) Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 53:1082–1089

    Article  PubMed  CAS  Google Scholar 

  10. Mitsushige S, Takahisa F, Naohito S, Akiko N, Masayoshi K, Haruhiko S, Akira H (2007) Effects of interleukin-10 gene polymorphism on the development of gastric cancer and peptic ulcer in Japanese subjects. J Gastroenterol Hepatol 22:1443–1449

    Article  Google Scholar 

  11. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354–362

    PubMed  Google Scholar 

  12. Correa P (1992) Human gastric carcinogenesis: a multistep and multifactorial process-first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res 52:6735–6740

    PubMed  CAS  Google Scholar 

  13. Peek R M Jr, Blaser MJ (2002) Helicobacter pylori and gastrointestinal adenocarcinomas. Nat Rev Cancer 2(1):28–37

    Article  PubMed  CAS  Google Scholar 

  14. Meira E, Xiao OS, Yong BX, Wong HC (2011) Fruit and vegetable consumption and risk of distal gastric cancer in the Shanghai women’s and men’s health studies. Am J Epidemiol 172(4):397–406

    Google Scholar 

  15. Hu JF, La Vecchia C, Morrison H (2011) Salt, processed meat and the risk of cancer. Eur J Cancer Prev 20(2):132–139

    Article  PubMed  CAS  Google Scholar 

  16. Siman JH, Forsgren A, Berglund G, Floren CH (2001) Tobacco smoking increases the risk for gastric adenocarcinoma among Helicobacter pylori-infected individuals. Scand J Gastroenterol 36:208–213

    Article  PubMed  CAS  Google Scholar 

  17. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH (2003) Meta-analysis of the relationship between CagA seropositivity and gastric cancer. Gastroenterology 125(6):1636–1644

    Article  PubMed  Google Scholar 

  18. Yamaji Y, Watabe H, Yoshida H, Kawabe T, Wada R, Mitsushima T, Omata M (2009) High-risk population for gastric cancer development based on serum pepsinogen status and lifestyle factors. Helicobacter 4(2):81–86

    Article  Google Scholar 

  19. The Eurogast Study Group (1993) An international association between Helicobacter pylori infection and gastric cancer. Lancet 341:1359–1362

    Article  Google Scholar 

  20. Konturek SJ, Starzynska T, Konturek PC, Karczewska E, Marlicz K, Lawniczak M, Jaroszewicz-Heigelman H, Bielanski W, Hartwich A, Ziemniak A, Hahn EG (2004) Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer. Scand J Gastroenterol 37:891–898

    Article  Google Scholar 

  21. Kikuchi S, Crabtree JE, Forman D, Kurosawa M (1999) Association between infections with CagA-positive or -negative strains of Helicobacter pylori and risk for gastric cancer in young adults. Research group on prevention of gastric carcinoma among young adults. Am J Gastroenterol 94:3455–3459

    Article  PubMed  CAS  Google Scholar 

  22. Rieder G, Merchant J, Haas R (2005) Helicobacter pylori Cag-type IV secretion system facilitates corpus colonization to induce precancerous conditions in Mongolian gerbils. Gastroenterology 128:1229–1242

    Article  PubMed  CAS  Google Scholar 

  23. Blaser MJ, Perez–Perez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmermann GN, Nomura A (1995) Infection with Helicobacter pylori strains possessing CagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 115(5):678–683

    Google Scholar 

  24. Hatakeyama M (2004) Oncogenic mechanisms of the Helicobacter pylori CagA protein. Nat Rev Cancer 4(9):688–694

    Article  PubMed  CAS  Google Scholar 

  25. Suerbaum S, Michetti P (2002) Helicobacter infection. N Engl J Med 347:1175–1186

    Article  PubMed  CAS  Google Scholar 

  26. Megraud F (2001) Impact of Helicobacter pylori virulence on the outcome of gastroduodenal diseases: lessons from the microbiologist. Dig Dis 19:99–103

    Article  PubMed  CAS  Google Scholar 

  27. Hynes RO (2002) Integrins bidirectional, allosteric signaling machines. Cell 110:673–687

    Article  PubMed  CAS  Google Scholar 

  28. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18:516–523

    Article  PubMed  CAS  Google Scholar 

  29. Blaser MJ, Berg DE (2001) H. pylori genetic diversity and risk of human disease. J Clin Invest 107:767–773

    Article  PubMed  CAS  Google Scholar 

  30. Parsonnent J (1998) H pylori—the size of the problem. Gut 43(suppl 1):3247–3249

    Google Scholar 

  31. Gebert B, Fischer W, Haas R (2004) The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol 152:205–220

    Article  PubMed  CAS  Google Scholar 

  32. Cover TL, Blanke SR (2005) Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 3:320–332

    Article  PubMed  CAS  Google Scholar 

  33. Kamangar F, Abnet CC, Hutchinson AA (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer. Cancer Causes Control 17:117–125

    Article  PubMed  Google Scholar 

  34. Suzuki S, Muroishi Y, Nakanishi I, Oda Y (2004) Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 39:220–230

    Article  PubMed  CAS  Google Scholar 

  35. Kondo S, Shinomura Y, Kanayama S (1994) Interleukin-1 beta inhibits gastric histamine secretion and synthesis in the rat. Am J Physiol 267:G966–G971

    PubMed  CAS  Google Scholar 

  36. Lee JY, Kim HY, Kim KH (2005) Association of polymorphism of IL-10 and TNF-A genes with gastric cancer in Korea. Cancer Let 225:207–214

    Article  CAS  Google Scholar 

  37. Bai XL, Sun LP, Liu J, Chen W, Zhang Y, Yuan Y (2008) Correlation of interleukin-10–1082G/A single nucleotide polymorphism to the risk of gastric cancer in North China: a case-control study. Ai Zheng 27:35–40

    PubMed  Google Scholar 

  38. El-Omar EM, Rabkin CS, Gammon MD (2003) Increased risk of non-cardia gastric cancer associated with pro-inflammatory cytokine gene polymorphisms. Gastroenterology 124:1193–1201

    Article  PubMed  CAS  Google Scholar 

  39. Zambon CF, Basso D, Navaglia F (2005) Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29:141–152

    Article  PubMed  CAS  Google Scholar 

  40. Cavet J, Middleton PG, Segall M, Noreen H, Davies SM, Dickinson AM (1999) Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants. Blood 94:3941–3946

    PubMed  CAS  Google Scholar 

  41. Schaaf BM, Boehmke F, Esnaashari (2003) H pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am J Respir Crit Care Med 168:476–480

    Article  PubMed  Google Scholar 

  42. Zhang Q, Li Y, Li X, Zhou W, Shi B, Chen H, Yuan W (2009) PARP-1 Val762 Ala polymorphism CagA? H. pylori infection and risk for gastric cancer in Han Chinese population. Mol Biol Rep 36(6):1461–1467

    Article  PubMed  CAS  Google Scholar 

  43. Konturek PC, Rembiasz K, Konturek SJ, Stachura J, Bielanski W, Galuschka K, Karcz D, Hahn EG (2003) Gene expression of ornithine decarboxylase, cyclooxygenase-2, and gastrin in atrophic gastric mucosa infected with Helicobacter pylori before and after eradication therapy. Dig Dis Sci 48:36–46

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This research was supported by National Natural Science Foundation of China (No. 30870364).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yumin Li.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zeng, X., Li, Y., Liu, T. et al. Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China. Mol Cell Biochem 362, 241–248 (2012). https://doi.org/10.1007/s11010-011-1149-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-1149-y

Keywords

Navigation